D-0450-2017 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0450-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Dec 28, 2016 and is designated Class II. Reason for recall: Failed Dissolution Specifications; 18 month stability time point The recall status is terminated (terminated Oct 19, 2017). Affected quantity: a) 42,984 and b) 7,764 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 8, 2017
Initiation Date
Dec 28, 2016
Termination Date
Oct 19, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 42,984 and b) 7,764 bottles

Product description

Flucanozole Tablets, USP, 100 mg, a) 30 count (NDC 55111-144-30) and b) 100 count (NDC 55111-144-01) bottles, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India

Reason for recall

Failed Dissolution Specifications; 18 month stability time point

Distribution pattern

Nationwide

Code information

a) 30 count C500224, exp 12/2016, C500846, exp 01/2017 b) 100 count C500224, exp 12/2016, exp 12/2016, C501608, exp 02/2017 and C503655, exp 04/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0450-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0450-2017. Report a data issue: hello@regdatalab.com.